propafenone has been researched along with Dizzyness in 8 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"The objective of this randomized, double-blind, placebo-controlled clinical trial was to test the efficacy and safety of a new sustained-release preparation of the antiarrhythmic drug propafenone (propafenone SR) in reducing the frequency of symptomatic arrhythmia recurrences in patients with atrial fibrillation (AF)." | 9.10 | Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. ( Carlson, M; Fava, G; Page, RL; Pritchett, EL; Undesser, K, 2003) |
"The efficacy of propafenone in the treatment of paroxysmal atrial fibrillation was investigated in 16 patients presenting with frequent and/or poorly tolerated paroxysmal atrial fibrillation despite prophylactic treatment in 13 patients." | 7.68 | [Intravenous and oral propafenone in the treatment and prevention of paroxysmal atrial fibrillation]. ( Bru, P; Cointe, R; Gerard, R; Lévy, S; Metge, M; Paganelli, F; Vrancea, F, 1993) |
"Twenty-one patients whose severe ventricular arrhythmias were not controlled by other currently used antiarrhythmic agents or who were intolerant of those drugs were treated with a new antiarrhythmic agent, propafenone." | 7.67 | Propafenone for the treatment of severe ventricular arrhythmias. ( Bar-Shlomo, B; Boroomand-Rashti, K; Rabkin, SW; Rotem, CE, 1984) |
"The objective of this randomized, double-blind, placebo-controlled clinical trial was to test the efficacy and safety of a new sustained-release preparation of the antiarrhythmic drug propafenone (propafenone SR) in reducing the frequency of symptomatic arrhythmia recurrences in patients with atrial fibrillation (AF)." | 5.10 | Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. ( Carlson, M; Fava, G; Page, RL; Pritchett, EL; Undesser, K, 2003) |
" Three months after starting citalopram, she experienced episodes of chest tightness and dizziness." | 3.74 | Adverse effects of propafenone after long-term therapy with the addition of citalopram. ( Garcia, A, 2008) |
"The efficacy of propafenone in the treatment of paroxysmal atrial fibrillation was investigated in 16 patients presenting with frequent and/or poorly tolerated paroxysmal atrial fibrillation despite prophylactic treatment in 13 patients." | 3.68 | [Intravenous and oral propafenone in the treatment and prevention of paroxysmal atrial fibrillation]. ( Bru, P; Cointe, R; Gerard, R; Lévy, S; Metge, M; Paganelli, F; Vrancea, F, 1993) |
"Twenty-one patients whose severe ventricular arrhythmias were not controlled by other currently used antiarrhythmic agents or who were intolerant of those drugs were treated with a new antiarrhythmic agent, propafenone." | 3.67 | Propafenone for the treatment of severe ventricular arrhythmias. ( Bar-Shlomo, B; Boroomand-Rashti, K; Rabkin, SW; Rotem, CE, 1984) |
"Two patients with recurrences of sustained VT in this group were later successfully treated with propafenone, 900 mg/day; overall, 8 of 9 patients with recurrences of sustained VT were successfully treated with 900 mg/day." | 1.27 | Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment. ( Ambrosioni, E; Bracchetti, D; Marchesini, B; Naccarella, F; Palmieri, M, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lip, GY | 1 |
Fauchier, L | 1 |
Freedman, SB | 1 |
Van Gelder, I | 1 |
Natale, A | 1 |
Gianni, C | 1 |
Nattel, S | 1 |
Potpara, T | 1 |
Rienstra, M | 1 |
Tse, HF | 1 |
Lane, DA | 1 |
Garcia, A | 1 |
Alexoudis, A | 1 |
Spyridonidou, A | 1 |
Pritchett, EL | 1 |
Page, RL | 1 |
Carlson, M | 1 |
Undesser, K | 1 |
Fava, G | 1 |
Rabkin, SW | 1 |
Rotem, CE | 1 |
Boroomand-Rashti, K | 1 |
Bar-Shlomo, B | 1 |
Naccarella, F | 1 |
Bracchetti, D | 1 |
Palmieri, M | 1 |
Marchesini, B | 1 |
Ambrosioni, E | 1 |
Cointe, R | 1 |
Metge, M | 1 |
Bru, P | 1 |
Vrancea, F | 1 |
Gerard, R | 1 |
Paganelli, F | 1 |
Lévy, S | 1 |
Cai, WM | 1 |
Chen, B | 1 |
Cai, MH | 1 |
Chen, Y | 1 |
Zhang, YD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation[NCT02145546] | Phase 4 | 600 participants (Anticipated) | Interventional | 2014-05-31 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for propafenone and Dizzyness
Article | Year |
---|---|
Atrial fibrillation.
Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Coun | 2016 |
2 trials available for propafenone and Dizzyness
Article | Year |
---|---|
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; C | 2003 |
The influence of CYP2D6 activity on the kinetics of propafenone enantiomers in Chinese subjects.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Area Under Curve; China; Cytochrome P-450 CYP2D | 1999 |
5 other studies available for propafenone and Dizzyness
Article | Year |
---|---|
Adverse effects of propafenone after long-term therapy with the addition of citalopram.
Topics: Accidental Falls; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Citalopram; Dizzin | 2008 |
Images in emergency medicine. Reversible QRS complex widening after oral administration of propafenone.
Topics: Administration, Oral; Aged; Atrial Fibrillation; Diagnosis, Differential; Dizziness; Electrocardiogr | 2010 |
Propafenone for the treatment of severe ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dizziness; Female; Humans; Male; Middle A | 1984 |
Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Dizziness; Female; Humans | 1984 |
[Intravenous and oral propafenone in the treatment and prevention of paroxysmal atrial fibrillation].
Topics: Administration, Oral; Adolescent; Adult; Aged; Atrial Fibrillation; Dizziness; Drug Evaluation; Fema | 1993 |